Clinical Trial

A Phase 1 Study of CLYM116 in Normal Healthy Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
This Phase 1, first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of CLYM116 in healthy volunteers.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-11-18; most recent amendment 2026-02-19.
Status change: Not Yet Recruiting → Recruiting 2026-01-08
Trial Details
NCT Number NCT07248865
Lead Sponsor Climb Bio, Inc.
Conditions Healthy Volunteers
Enrollment 48 participants
Start Date 2025-12-02
Primary Completion 2026-07 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-20